News

Recipharm, a leading contract development and manufacturing organisation (CDMO), has now secured supply of the active pharmaceutical ingredient (API) chloroquine phosphate for its drug Klorokinfosfat RPH Pharma and commenced manufacture of the product. The move comes following reports that chloroquine...

Humanigen, Inc., has dosed the first COVID-19 patient in its Phase III study for lenzilumab, its Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody. Catalent provides clinical supply support to Humanigen and its partners from its Philadelphia facility. “We...

The U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has awarded Tangen the Second Option of a contract to develop a molecular diagnostic platform that can be used by Tangen Biosciences Inc. to...

CPhI South East Asia – organised by Informa Markets – has postponed its rescheduled event to November 4-6, 2020 to provide more time for positive business conditions to return and for global disruption to ease. “Moving the event to November...

Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate...

Singapore’s Oliver Healthcare Packaging received the Packaging Design of the Year Award at the recently concluded Healthcare Asia Pharma Awards 2020. The award recognised the company’s proprietary Autoclavable Dispos-a-vent® Barrier Pouch, which provides medical device manufacturers a pouch option for...

COVID-19 Vaccine: Israeli Defence Minister Naftali Bennett was shown the "antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill", a statement from his office said. Israeli Defence Minister Naftali Bennett...